Table 2 Spearman’s correlation coefficients between 14-3-3β and other clinical indices in asthmatic subgroup
Acute Exacerbation group | Chronic Persistent group | |||
|---|---|---|---|---|
Serum 14-3-3β (ng/mL) | ||||
r | P | r | P | |
FeNO (ppb) | 0.292 | 0.032 | − 0.192 | 0.190 |
Peripheral eosinophil count (4 × 109/L) | 0.328 | 0.016 | − 0.187 | 0.193 |
FVC (L) | 0.072 | 0.605 | − 0.166 | 0.251 |
FVC% pred (%) | 0.039 | 0.780 | 0.156 | 0.280 |
FEV1 (L) | − 0.105 | 0.449 | − 0.297 | 0.036 |
FEV1% pred (%) | − 0.167 | 0.229 | 0.067 | 0.642 |
FEV1/FVC (L) | − 0.293 | − 0.031 | − 0.200 | 0.165 |